AGL 40.00 No Change ▼ 0.00 (0%)
AIRLINK 130.95 Increased By ▲ 1.42 (1.1%)
BOP 6.75 Increased By ▲ 0.07 (1.05%)
CNERGY 4.71 Increased By ▲ 0.08 (1.73%)
DCL 8.99 Increased By ▲ 0.05 (0.56%)
DFML 43.24 Increased By ▲ 1.55 (3.72%)
DGKC 83.98 Increased By ▲ 0.21 (0.25%)
FCCL 32.80 Increased By ▲ 0.03 (0.09%)
FFBL 77.60 Increased By ▲ 2.13 (2.82%)
FFL 11.54 Increased By ▲ 0.07 (0.61%)
HUBC 111.00 Increased By ▲ 0.45 (0.41%)
HUMNL 14.53 Decreased By ▼ -0.03 (-0.21%)
KEL 5.46 Increased By ▲ 0.07 (1.3%)
KOSM 8.46 Increased By ▲ 0.06 (0.71%)
MLCF 40.00 Increased By ▲ 0.21 (0.53%)
NBP 60.76 Increased By ▲ 0.47 (0.78%)
OGDC 198.50 Decreased By ▼ -1.16 (-0.58%)
PAEL 26.80 Increased By ▲ 0.15 (0.56%)
PIBTL 7.90 Increased By ▲ 0.24 (3.13%)
PPL 158.98 Increased By ▲ 1.06 (0.67%)
PRL 26.53 Decreased By ▼ -0.20 (-0.75%)
PTC 18.85 Increased By ▲ 0.39 (2.11%)
SEARL 82.66 Increased By ▲ 0.22 (0.27%)
TELE 8.43 Increased By ▲ 0.12 (1.44%)
TOMCL 34.80 Increased By ▲ 0.29 (0.84%)
TPLP 9.19 Increased By ▲ 0.13 (1.43%)
TREET 17.40 Decreased By ▼ -0.07 (-0.4%)
TRG 61.85 Increased By ▲ 0.53 (0.86%)
UNITY 27.83 Increased By ▲ 0.40 (1.46%)
WTL 1.39 Increased By ▲ 0.01 (0.72%)
BR100 10,490 Increased By 83.1 (0.8%)
BR30 31,857 Increased By 144.1 (0.45%)
KSE100 98,057 Increased By 728.1 (0.75%)
KSE30 30,431 Increased By 239 (0.79%)
World

'Real-world' UK data shows 70pc decline in COVID infections after first Pfizer shot

  • "Overall, we're seeing a really strong effect to reducing any infection, asymptomatic and symptomatic," PHE's strategic response director Susan Hopkins told a media briefing.
  • "Hospitalisation and deaths rates are falling in all age groups, but the oldest age groups are seeing the fastest decline since the peak in mid-January," a PHE statement said.
Published February 22, 2021

LONDON: England's coronavirus vaccine campaign is significantly reducing cases of COVID-19, with a drop of around 70% in infections among healthcare workers who have had a first dose of the Pfizer-BioNTech shot, British health officials said on Monday.

Data analysed by Public Health England (PHE) showed the Pfizer provided high levels of protection against infection and symptomatic disease from a single dose, and that hospitalisation and death from COVID-19 will be reduced by more 75% in elderly people who have had a first dose.

"Overall, we're seeing a really strong effect to reducing any infection, asymptomatic and symptomatic," PHE's strategic response director Susan Hopkins told a media briefing.

PHE's head of immunisation Mary Ramsay described the data as "strong evidence that the Pfizer-BioNTech vaccine is stopping people from getting infected, while also protecting cases against hospitalisation and death".

"We should be very encouraged by these initial findings," she said.

PHE's findings came from two separate analyses - one is an ongoing study in healthcare workers, and the second is an assessment of testing data in people aged 80 and over.

Evidence from the elderly group showed that one dose of the Pfizer shot is 57% effective against symptomatic COVID-19 disease, PHE said, and early data suggest the second dose improves protection to more than 85%.

"Hospitalisation and deaths rates are falling in all age groups, but the oldest age groups are seeing the fastest decline since the peak in mid-January," a PHE statement said.

The vaccine also provides protection against the so-called British variant of the SARS-CoV-2 coronavirus, it added.

The PHE data come as preliminary study findings from Scotland on Monday also showed the vaccination drive there is working, markedly reducing the risk of hospitalisation for COVID-19.

Scottish researchers said those findings suggested that both the Pfizer and the Oxford-AstraZeneca COVID-19 vaccines are highly effective in preventing severe infections.

Comments

Comments are closed.